Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Clinical trial NCT00379197 · TERMINATED
Trial details
- NCT number
- NCT00379197
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2013-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.